HCA Healthcare, Inc. (NYSE:HCA) SVP Chad J. Wasserman Sells 652 Shares of Stock

HCA Healthcare, Inc. (NYSE:HCAGet Free Report) SVP Chad J. Wasserman sold 652 shares of the firm’s stock in a transaction dated Friday, February 2nd. The shares were sold at an average price of $312.04, for a total transaction of $203,450.08. Following the transaction, the senior vice president now owns 290 shares of the company’s stock, valued at approximately $90,491.60. The transaction was disclosed in a document filed with the SEC, which is available at this link.

HCA Healthcare Trading Down 1.2 %

Shares of HCA stock opened at $306.83 on Wednesday. HCA Healthcare, Inc. has a 1 year low of $215.96 and a 1 year high of $314.82. The firm’s fifty day simple moving average is $276.05 and its 200 day simple moving average is $262.38. The firm has a market capitalization of $82.13 billion, a P/E ratio of 16.17, a price-to-earnings-growth ratio of 1.56 and a beta of 1.65. The company has a current ratio of 1.18, a quick ratio of 1.02 and a debt-to-equity ratio of 35.07.

HCA Healthcare (NYSE:HCAGet Free Report) last announced its earnings results on Tuesday, January 30th. The company reported $5.90 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $5.05 by $0.85. HCA Healthcare had a net margin of 8.07% and a return on equity of 996.30%. The business had revenue of $17.30 billion for the quarter, compared to analyst estimates of $16.51 billion. During the same quarter in the previous year, the firm posted $4.64 earnings per share. HCA Healthcare’s revenue was up 11.7% compared to the same quarter last year. As a group, sell-side analysts predict that HCA Healthcare, Inc. will post 20.38 EPS for the current year.

HCA Healthcare Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, March 29th. Shareholders of record on Friday, March 15th will be issued a $0.66 dividend. This represents a $2.64 annualized dividend and a yield of 0.86%. The ex-dividend date is Thursday, March 14th. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.60. HCA Healthcare’s payout ratio is 13.91%.

HCA Healthcare announced that its Board of Directors has initiated a stock buyback plan on Tuesday, January 30th that allows the company to repurchase $6.00 billion in outstanding shares. This repurchase authorization allows the company to reacquire up to 7.4% of its shares through open market purchases. Shares repurchase plans are often a sign that the company’s board of directors believes its stock is undervalued.

Institutional Investors Weigh In On HCA Healthcare

Institutional investors and hedge funds have recently bought and sold shares of the business. Stone House Investment Management LLC bought a new stake in shares of HCA Healthcare in the 3rd quarter worth about $25,000. Centerpoint Advisors LLC bought a new stake in HCA Healthcare during the 4th quarter worth about $27,000. Bruce G. Allen Investments LLC bought a new stake in HCA Healthcare during the 4th quarter worth about $28,000. Northwest Investment Counselors LLC grew its holdings in HCA Healthcare by 92.9% during the 3rd quarter. Northwest Investment Counselors LLC now owns 108 shares of the company’s stock worth $27,000 after acquiring an additional 52 shares during the last quarter. Finally, BluePath Capital Management LLC bought a new stake in HCA Healthcare during the 3rd quarter worth about $27,000. Institutional investors own 62.73% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on HCA. Truist Financial raised their price objective on shares of HCA Healthcare from $320.00 to $345.00 and gave the company a “buy” rating in a research report on Wednesday, January 31st. Citigroup decreased their target price on shares of HCA Healthcare from $324.00 to $279.00 and set a “buy” rating for the company in a report on Wednesday, October 25th. Oppenheimer reiterated an “outperform” rating and issued a $315.00 target price on shares of HCA Healthcare in a report on Wednesday, January 17th. Royal Bank of Canada raised their target price on shares of HCA Healthcare from $308.00 to $322.00 and gave the stock an “outperform” rating in a report on Wednesday, January 31st. Finally, Stephens restated an “overweight” rating and set a $280.00 price target on shares of HCA Healthcare in a report on Friday, November 10th. Four analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. According to MarketBeat.com, HCA Healthcare has a consensus rating of “Moderate Buy” and an average target price of $304.26.

Check Out Our Latest Report on HCA Healthcare

HCA Healthcare Company Profile

(Get Free Report)

HCA Healthcare, Inc, through its subsidiaries, provides health care services in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Further Reading

Insider Buying and Selling by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.